Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines.
Saved in:
| Title: | Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines. |
|---|---|
| Authors: | Shae D; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States., Baljon JJ; Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States., Wehbe M; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States., Christov PP; Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee 37232, United States., Becker KW; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States., Kumar A; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.; Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee 37212, United States., Suryadevara N; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.; Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee 37212, United States., Carson CS; Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States., Palmer CR; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States., Knight FC; Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States., Joyce S; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.; Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee 37212, United States.; Vanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.; Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States., Wilson JT; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States.; Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States.; Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee 37232, United States.; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.; Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee 37212, United States.; Vanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.; Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States. |
| Source: | ACS nano [ACS Nano] 2020 Aug 25; Vol. 14 (8), pp. 9904-9916. Date of Electronic Publication: 2020 Jul 31. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101313589 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-086X (Electronic) Linking ISSN: 19360851 NLM ISO Abbreviation: ACS Nano Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
